To further validate if Wnt5b‐β‐catenin pathway is responsible for 4‐PBA promoted LCSCs initiation and HCC development, XAV939, an inhibitor to block the activation of β‐catenin signaling was utilized. Here, WNT5B is linked to hepatocellular carcinoma.